Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Sep 21, 2023

SELL
$26.46 - $37.15 $926,100 - $1.3 Million
-35,000 Reduced 76.25%
10,900 $370,000
Q3 2021

Nov 15, 2021

SELL
$26.46 - $37.15 $926,100 - $1.3 Million
-35,000 Reduced 76.25%
10,900 $370,000
Q2 2021

Aug 20, 2021

SELL
$32.73 - $47.95 $149 Million - $218 Million
-4,544,100 Reduced 99.0%
45,900 $1.68 Million
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $149 Million - $218 Million
4,544,100 Added 9900.0%
4,590,000 $1.68 Million
Q1 2021

Sep 21, 2023

BUY
$40.39 - $56.73 $1.85 Million - $2.6 Million
45,900 New
45,900 $2.06 Million
Q1 2021

May 14, 2021

BUY
$40.39 - $56.73 $1.85 Million - $2.6 Million
45,900 New
45,900 $2.06 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.